Clinical implications of p57 KIP2 expression in breast cancer.

Xu, Xiao-Yin; Wang, Wen-Qian; Zhang, Lei; Li, Yi-Ming; Tang, Miao; Jiang, Nan; Cai, Shou-Liang; Wei, Liang; Jin, Feng; Chen, Bo

Xu, Xiao-Yin; Wang, Wen-Qian; Zhang, Lei; Li, Yi-Ming; Tang, Miao; Jiang, Nan; Cai, Shou-Liang; Wei, Liang; Jin, Feng; Chen, Bo.

Affiliation

Xu XY; Department of Surgical Oncology, First Hospital of China Medical University, Shenyang, China.

Asian Pac J Cancer Prev ; 13(10): 5033-6, 2012.

Article in En | MEDLINE | ID: mdl-23244105

Subject(s)

Breast Neoplasms/metabolism; Breast/metabolism; Carcinoma, Ductal, Breast/metabolism; Cyclin-Dependent Kinase Inhibitor p57/metabolism; Adult; Aged; Aged, 80 and over; Breast/pathology; Breast Neoplasms/drug therapy; Breast Neoplasms/mortality; Carcinoma, Ductal, Breast/drug therapy; Carcinoma, Ductal, Breast/mortality; Case-Control Studies; Female; Follow-Up Studies; Humans; Immunoenzyme Techniques; Lymphatic Metastasis; Middle Aged; Neoplasm Staging; Prognosis; Receptor, ErbB-2/metabolism; Survival Rate

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Breast / Breast Neoplasms / Carcinoma, Ductal, Breast / Cyclin-Dependent Kinase Inhibitor p57 Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Aged / Aged80 / Female / Humans / Middle aged Language: En Journal: Asian Pac J Cancer Prev Journal subject: NEOPLASIAS Year: 2012 Document type: Article Affiliation country: China Country of publication: Thailand

Search on Google

Add to My VHL

XML

PubMed Links